Most large research universities are essentially running two separate IT organizations. Research computing serves the scientific mission, HPC clusters, genomics pipelines, federal compliance requirements. Administrative IT serves the institutional mission, student systems, financial operations, HR platforms. Two teams, two vendor ecosystems, two security frameworks, two budgets.
For a long time, this felt like a reasonable way to organize things. Research computing has specialized needs. Administrative IT has different ones. Keep them separate and each team can focus on what they know.
That logic is getting expensive, and the compliance pressure now bearing down on research computing is making it urgent.
Running parallel stacks is costing more than anyone has measured
Two infrastructure ecosystems running side by side, each managing the same fundamental problems, containerized workloads, security controls, audit logging, access management, just doing it separately with their own tools, vendors, and teams.
The inefficiency compounds with every new cloud service adopted on either side, and the total cost never appears in a single line item, which is why it persists. When universities actually measure it, the per-seat infrastructure cost of running parallel stacks is significant, typically 35 to 50 percent more than a consolidated approach would require.
Here’s what’s possible instead: one platform that handles FERPA controls for student data and NIST 800-171 controls for federal research workloads. Both missions, one runtime. Research computing and administrative IT sharing infrastructure, and, sharing costs instead of duplicating them.
NSF and DoD are enforcing NIST 800-171 compliance for research involving Controlled Unclassified Information.
Most university IT environments weren’t designed to document 110 security controls across a hybrid cloud research infrastructure. The result is a compliance gap that’s either sitting in the last assessment or hasn’t been assessed at all. Either way, the risk is real, and the institutions caught unprepared aren’t small schools with limited resources. They’re major research universities that treated federal grant compliance as a research administration problem instead of an infrastructure one.
When the controls are built into the platform, when the runtime for research workloads maps directly to NIST 800-171 and CMMC Level 2, and the data fabric handles CUI access without requiring researchers to change their workflows, compliance becomes continuous rather than a per-grant documentation exercise. Universities that have done this have completed NIST 800-171 assessments without adding compliance staff, and without slowing down active research programs.
Researchers shouldn’t wait weeks to access their own data
A researcher needs data for a grant proposal; they submit a request. Weeks later, IT provisions the dataset. The proposal deadline has moved. The preliminary data that would have strengthened the application arrived too late to matter.
This can happen at research universities, and it is quietly costing institutions grant competitiveness in ways that are hard to quantify but easy to observe: proposals that go out without the best supporting data, publications that follow competitors, funding renewals that miss the window.
It’s not a staffing problem; it’s a data architecture problem. When researchers can access datasets, clinical trial data, and institutional analytics through a single interface, without a provisioning ticket, without waiting on IT, the dynamic changes completely. The three-week wait becomes same-day access and the proposal goes out with the best data. The preliminary analysis that should have been done last month actually gets done.
research data provisioning when architecture replaces ticketing
The research universities gaining ground on grant competitiveness aren’t the ones with the
largest IT budgets. They’re the ones that stopped making researchers wait on infrastructure.
Life sciences have always had a complicated relationship with infrastructure. On one hand, it’s mission-critical, validated environments, FDA compliance, data integrity. On the other hand, it’s historically been treated as a cost center, something to manage carefully and not change too often.
That approach is becoming a competitive liability. The organizations bringing drugs to market faster, running more efficient trials, and deploying AI discovery models at scale are doing it in part because their infrastructure lets them move faster than their competitors, and the gap is widening.
You’re re-validating the same environment over and over. You shouldn’t have to.
Here’s a question worth answering honestly: how long does it take your team to validate a new environment for a clinical trial application? For most pharma and biotech organizations, the answer is weeks to months, per application. Every time a dependency changes, every time a new study spins up.
That’s not a resourcing problem; it’s an architecture problem. Validation happens at the application level because the underlying environment isn’t consistent or trustworthy enough to validate once and rely on. So every new study, every dependency update, every new application triggers a fresh validation cycle, consuming weeks of IT cost that should be going somewhere else.
When the environment itself becomes the validated foundation, a GxP-aligned platform where every application inherits the validation posture automatically, the per-application cycle disappears. The organizations reporting 50 to 70 percent reductions in validation time aren’t doing validation more efficiently. They’ve changed what needs to be validated.
Your AI models are ready. Your data pipeline isn’t.
The investment in AI for drug discovery is real and accelerating. The models being built in many organizations are genuinely capable of compressing timelines, but in most pharma environments, the bottleneck isn’t the model, it’s the data.
Genomic datasets managed by research informatics, clinical trial data owned by a separate data management team. Manufacturing and assay data in a third system. Getting a unified dataset for model training requires weeks of data engineering per study, per model, per iteration. The data scientists are ready, the infrastructure isn’t.
A unified data fabric, one that makes all three datasets available through a single namespace with the 21 CFR Part 11 audit lineage your regulatory team needs, changes the equation. The pipeline that was taking weeks takes hours. The model that was waiting on data starts getting data.
The organizations compressing drug discovery timelines aren’t just investing in better AI. They’re investing in infrastructure that lets the AI actually run.
reduction in environment validation time at leading life sciences organizations
The compliance debt that won’t survive your next inspection
Most life sciences IT leaders know exactly where the risk is in their environment. The system that’s been running since the last platform migration that never quite finished. The study still active on infrastructure that predates the current compliance framework. The validation documentation that technically exists but wouldn’t hold up to a close reading by an FDA inspector.
This isn’t hypothetical, and the reason it persists is usually the same: fixing it at the application level is a years-long project with no clean finish line. The compliance framework keeps moving while the remediation is underway.
Fixing it at the platform level is a different kind of project. When the environment is the validated foundation, compliance debt stops accumulating with every new study. When the data layer has built-in lineage and unified governance, data provenance is something you can demonstrate, not reconstruct. The posture that satisfies an FDA inspector is the same posture that lets your teams move fast, because it’s in the infrastructure, not layered on top of it afterward.
Multi-site manufacturers are good at measuring a lot of things. Defect rates, cycle times, throughput per line. However, here’s one cost that almost never shows up in any dashboard: the time it takes to get a validated application from the team that built it to the plant floor where it needs to run.
That lag is compounding across every facility, every quarter. It costs more than most operations leaders realize.
The deployment lag problem — and why it keeps getting worse
Talk to a multi-site manufacturer and you’ll often hear the same story. The improvement application is built; the process change is validated, and the ROI is documented. Then it waits, sometimes for weeks, while central IT tries to validate it against an environment that doesn’t match the one where it was developed.
By the time the application actually reaches the plant floor, the operational context has shifted. The defect rate the app was designed to address has changed. The production line has been reconfigured. The window for the improvement has closed.
The root cause isn’t IT being slow, it’s environment inconsistency. When no two facilities share the same runtime configuration, every deployment requires custom validation. The same application has to be re-validated at each site because there’s no common foundation to rely on.
When there is a common foundation, one consistent runtime across every site, plant teams push updates through the same validated path every time. No exceptions. No delays. No rework.
The OT/IT security gap that keeps showing up in assessments
Here’s something that comes up in almost every third-party security assessment at a large manufacturer: the boundary between operational technology and enterprise IT isn’t as clean as it looks on paper.
The network convergence happened because it needed to. Production data needs to get to enterprise systems and analytics need to run on manufacturing data. That’s the right direction but the security controls on each side were built independently. Different configurations, different access models, different audit trails. When an examiner asks for unified evidence of control consistency across both environments, the gap becomes visible fast.
The fix isn’t to undo the convergence, it’s to build a runtime that spans both environments with consistent network segmentation, role-based access controls, and audit logging. When that’s in place, audit prep compresses from weeks to days, and the findings that kept reappearing in the same section of every assessment finally get closed.
The M&A infrastructure debt nobody budgets for
Manufacturers that grow through acquisition inherit a lot of things alongside the revenue: customer relationships, production capacity, talent…..and infrastructure debt.
The acquired company’s container platform. The legacy environment that predates the current architecture strategy. The cloud-native setup the innovation team built without coordinating with central IT. Three platforms, three licensing contracts. Three security postures requiring separate management across every facility the acquisition added.
The cost of all this is never visible in a single line item. Which is exactly why it survives budget cycle after budget cycle. When it does get consolidated onto one enterprise-grade platform, manufacturers consistently find they were funding 35 to 50 percent more complexity than the business actually required. The security exposure that kept appearing in third-party assessments turns out to be a platform problem, not a structural one.
infrastructure cost reduction after platform consolidation
Better yet: when you’re ready to unify operational and enterprise data across facilities, you don’t have to start over. The same platform foundation supports both.
For a long time, healthcare IT was treated like plumbing, important, but invisible. As long as things kept running, nobody asked too many questions. That has changed. Integration failures are affecting patient care. Compliance gaps are showing up in risk assessments. Population health programs are stalling. Most of the time, the root cause isn’t clinical, it’s infrastructure.
The health systems making real progress have figured this out and responded accordingly.
Your EHR isn’t broken. Your environment is.
Clinical IT teams spend a lot of time chasing EHR integration failures. Here’s the thing: most of the time, the integration itself isn’t the problem. The environment it runs in is inconsistent.
The same application behaves differently across dev, staging, and production because the container configurations don’t match. The failure only happens in the environment that’s hardest to inspect. And it’s nearly impossible to reproduce reliably because no two environments are set up the same way.
This is the technical debt that accelerated cloud adoption since 2020 has created. Health systems that moved fast didn’t always move consistently. When the runtime environment is the same everywhere, with HIPAA controls, audit logging, and network segmentation built in, those integration failures stop. Not because you fixed the integration, because you fixed the foundation it runs on.
FHIR compliance isn’t a project. It’s an infrastructure problem.
CMS Interoperability Rule enforcement has arrived. The deadlines have passed. Patient data access requirements are real and not going anywhere, and most clinical data environments were not built for on-demand API access.
Health systems that haven’t addressed this are sitting in one of two places: a tangle of API gateways that create security exposure, or a compliance gap that’s quietly living in the last risk assessment. Neither is a stable position.
The organizations handling this well aren’t building separate compliance infrastructure for each new mandate. They’re building data infrastructure that’s interoperable from the ground up, connecting on-premises clinical systems to cloud environments without rebuilding every integration from scratch. As a byproduct, they’re getting the unified patient data environment that population health programs have been asking for years.
Population health is stalling at the data layer, not the insight layer
Population health is a top priority at most health systems. It’s also, at most health systems, significantly behind where leadership expected it to be by now.
The problem usually isn’t the analytics platform, it isn’t the data team. It’s that patient data, claims data, and social determinants data all live in separate silos: and getting a unified dataset for any real analysis means filing a data engineering ticket and waiting weeks.
When you can get cross-system data access without a provisioning queue, the economics of population health analytics change completely. The insight that used to take a quarter to produce takes a week. The program that’s been a roadmap item becomes an operational capability.
data access time for population health analytics when silos become a unified namespace
Most financial institutions are spending a lot of time and money managing infrastructure problems that should have been solved at the platform level. Audit prep that drains hundreds of hours, fraud models sitting idle while data pipelines catch up. Multiple Kubernetes environments that nobody really wants to deal with but nobody wants to touch either.
These aren’t unique problems, and they’re not inevitable ones. Here’s what’s actually going on, and what the institutions pulling ahead are doing differently.
Ask anyone who runs infrastructure for a bank or credit union how long audit prep takes. You’ll hear numbers like 200 to 400 hours per cycle. Often much of that time is spent doing one thing: manually documenting Kubernetes configurations that, in a well-built environment, should already be audit-ready.
SOX, PCI-DSS, FFIEC — none of these frameworks care how modern your stack is. They care whether you can prove it’s controlled, and if your security team is spending weeks assembling evidence for examiners, they’re not actually managing risk. They’re reporting on it after the fact.
The fix isn’t more compliance headcount, it’s a platform where audit trails, network segmentation, and access controls are built in from the start, so every application that runs on it inherits those controls automatically. No manual documentation. No scrambling before an exam. Just continuous readiness.
Here’s a scenario that plays out constantly in financial services: the data team builds a solid fraud detection model, yhen everyone waits weeks for the data pipeline to catch up.
Core banking data lives in one system, transaction data in another. Customer behavior data somewhere in between. Getting a clean, unified dataset for model training means weeks of data engineering work that doesn’t move any business needle, and while that work is happening, fraud is occurring at real-time speed.
The institutions deploying models fastest aren’t the ones with the best data scientists. They’re the ones who stopped making their data scientists wait. When all those data sources are available through a single unified namespace, with the lineage tracking compliance requires and the access speed analytics needs, the pipeline stops being the bottleneck.
time to a unified dataset when data silos are replaced with a data fabric
A lot of large financial institutions are quietly running two or three container environments at the same time. One the enterprise team standardized on, one that showed up with an acquisition. One a trading desk stood up years ago that nobody wants to migrate but everyone wishes would go away.
Each one has its own licensing costs, its own support overhead, and its own security posture that has to be documented separately for every audit. The total cost is never visible in a single line item, which is exactly why it persists through budget cycle after budget cycle.
When institutions consolidate onto one enterprise-grade platform, they consistently find they were funding 50 to 60 percent more complexity than the business actually needed. Fewer audit exceptions. One security posture that holds up to scrutiny. And a foundation that can grow with the business instead of fighting it.
excess infrastructure complexity eliminated after platform consolidation
